GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ISU Abxis Co Ltd (XKRX:086890) » Definitions » Equity Investments

ISU Abxis Co (XKRX:086890) Equity Investments


View and export this data going back to 2009. Start your Free Trial

What is ISU Abxis Co Equity Investments?

Equity Investments only applies to insurance companies.


ISU Abxis Co Business Description

Traded in Other Exchanges
N/A
Address
3Fl. Kookje Bldg, 90-1 Daeshin-dong, Seodaemun-gu, Seoul, KOR, 120-160
ISU Abxis Co Ltd is engaged in developing and manufacturing therapeutic antibodies in South Korea. It offers Abciximab, Clotinab, Abcertin, and Fabagal used to treat incurable diseases such as cancer and rare diseases.